AN
Cellbxhealth PLC
ANPCF · OTC
$0.02 +0.00% (+$0.00)
Market Cap £16.7M
P/E Ratio -
Div. Yield -
ROE 343.50%
Piotroski F-Score Weak
2/9Valuation
25 /100
Expensive P/B 4.10x
P/S 9.71x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 22.96%
Rev. growth 41.37%
FCF growth N/A
Profitability
0 /100
Weak Net margin 1,125.05%
Op. margin 1,127.69%
FCF margin 761.66%
Quality
3 /100
Poor ROE 343.50%
ROA 250.13%
Asset turnover 0.22x
Debt
68 /100
Low Current ratio 2.54x
Int. coverage -85.28x
Debt/Equity 0.32x
Stability
31 /100
Unstable Rev. volatility 55.59%
EPS volatility 35.11%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ANPCF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Peter Michael Collins
Employees
119
Headquarters
Guildford
Nadcházející události
29 DUB
Earnings
Upcoming earnings report